TNXP
Tonix Pharmaceuticals Holding Corp
Price:  
0.55 
USD
Volume:  
1,838,249.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

TNXP WACC - Weighted Average Cost of Capital

The WACC of Tonix Pharmaceuticals Holding Corp (TNXP) is 6.2%.

The Cost of Equity of Tonix Pharmaceuticals Holding Corp (TNXP) is 8.50%.
The Cost of Debt of Tonix Pharmaceuticals Holding Corp (TNXP) is 5.00%.

Range Selected
Cost of equity 7.00% - 10.00% 8.50%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 5.4% - 7.0% 6.2%
WACC

TNXP WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.68 0.92
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.00% 10.00%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0.91 0.91
Cost of debt 5.00% 5.00%
After-tax WACC 5.4% 7.0%
Selected WACC 6.2%